Drug Profile
Research programme: calcitonin gene related peptide receptor antagonists - Bristol-Myers Squibb
Alternative Names: BMS-694153Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Amides; Imidazoles; Indazoles; Piperidines; Quinazolinones
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Migraine in USA (Intranasal)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Migraine in USA (SC)
- 11 Apr 2013 Preclinical development is ongoing in USA